Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

NNVC
NanoViricides Inc.
stock NYSEAMERICAN

Market Open
Jun 4, 2025 1:21:25 PM EDT
1.55USD+5.442%(+0.08)276,941
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 4, 2025 9:27:30 AM EDT
1.57USD+6.803%(+0.10)30,786
After-hours
Jun 3, 2025 4:48:30 PM EDT
1.54USD+3.010%(+0.05)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Nov 19, 2021
04:40PM EST  NanoViricides Shares Unaffected As Traders Circulate Seeking Alpha Blogpost From Contributor White Diamond Research 'NanoViricides Will Return To $3-$5 As Soon As The Coronavirus Newsflow Fades'   Benzinga
Nov 16, 2021
06:55AM EST  Nanoviricides Late Monday In Quarterly Report Q1 EPS $(0.23) Down From $(0.22) YoY   Benzinga
Nov 15, 2021
10:57AM EST  EXCLUSIVE: NanoViricides Completes Oral Gummies, Lung Inhalation Formulations For COVID-19 Treatment   Benzinga
10:49AM EST  EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate   Benzinga
10:48AM EST  EXCLUSIVE: NanoViricides Says 'NV-CoV-2 has been found to be non-immunogenic and non-allergenic. Further, it has not caused any hypersensitivity or adverse reactions at injection site or other adverse events in multiple animal studies.'   Benzinga
10:48AM EST  EXCLUSIVE: NanoViricides Reports It Has Completed Its Oral Gummies And Lung Inhalation Formulations Development For Its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2   Benzinga
Oct 13, 2021
01:38PM EDT  NanoViricides Highlights Filing Of 10-K   Benzinga
Oct 11, 2021
10:16AM EDT  NanoViricides COVID-19 Treatment Candidate Found Effective Against Coronavirus Variants In Lab Study   Benzinga
08:25AM EDT  NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity   Benzinga
06:15AM EDT  EXCLUSIVE: NanoVircides Reports 'both the drug candidate NV-CoV-2 and a positive control antibody specific to the Spike antigen S1 of the SARS-CoV-2 virus suppressed the infection by the SARS-CoV-2-pseudovirions in cell culture studies'   Benzinga
06:15AM EDT  EXCLUSIVE: NanoViricides Reports Its COVID-19 Drug Candidate Effective Against SARS-CoV-2 In A Standard Cell Culture Pseudovirion Assay   Benzinga
Oct 5, 2021
08:32AM EDT  NanoViricides Leaps Forward in its Quest to Defeat COVID-19   Benzinga
06:48AM EDT  NanoViricides Presents Update Of Pan-Coronavirus COVID-19 Drug Development Program At Benzinga Healthcare Conference   RTTNews
06:46AM EDT  NanoViricides Highlights Sept. 30 Presentation At Benzinga Healthcare Small Cap Conference   Benzinga
06:45AM EDT  NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development   PR Newswire
Sep 27, 2021
08:57AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Monday, Sept. 27, 2021: BYND, RCAT, BBIG, BBBY, NNVC   Benzinga
06:43AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 6.15 A.M. EDT).   RTTNews
Sep 22, 2021
06:48AM EDT  NanoViricides Reports On Advantages Gained By Remdesivir Encapsulation Within Its COVID-19 Candidate NV-CoV-2   RTTNews
06:45AM EDT  to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug   PR Newswire
Sep 21, 2021
12:39PM EDT  Nanoviricides Option Alert: Oct 15 $7.5 Calls Sweep (3) near the Ask: 114 @ $2.264 vs 127 OI; Earnings 11/15 After Close [est] Ref=$7.5101   Benzinga
11:29AM EDT  NanoViricides 8-K Shows Co. Was Advised Article Was Published By Third Party Which Received Info Under Embargo From Co.'s Public Relations Provider; Filing Confirms Earlier Press Release Reported By Benzinga   Benzinga
09:27AM EDT  BZ NOTE: NanoViricides Earlier Posted, Exclusively Via A Benzinga Pro Report, News Of DATA For Its COVID-19 Candidate, Showed 'Almost double the remdesivir remained intact in plasma when given as the encapsulated NV-CoV-2-R form'   Benzinga
09:23AM EDT  NonoViricides Shares Halted News Pending   Benzinga
06:15AM EDT  EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile   Benzinga
06:15AM EDT  EXCLUSIVE: NanoViricides Highlights 'significant advantages gained by remdesivir encapsulation' Within Its NV-CoV-2 COVID-19 Candidate   Benzinga
06:15AM EDT  UPDATE: Nanoviricides Says 'Almost double the remdesivir remained intact in plasma when given as the encapsulated NV-CoV-2-R form' When Compared To Standard Remdesivir Formulation In SBECD   Benzinga
Sep 15, 2021
06:43AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 6.10 A.M. EDT).   RTTNews
Sep 14, 2021
08:56AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Sept. 14, 2021: LEN, LICD, HLF, NNVC, PROG   Benzinga
07:50AM EDT  The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout   Benzinga
06:58AM EDT  NanoViricides Completes Licensing For Coronavirus Field For Drug Commercialization From TheraCour Pharma   RTTNews
06:54AM EDT  NanoViricides Completes Licensing for Coronavirus Field which Includes Current   PR Newswire
06:07AM EDT  EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact   Benzinga
Jul 16, 2021
01:10PM EDT  COVID-19 Variants: What the Future Could Look Like After the Pandemic   Benzinga
Jun 28, 2021
08:29AM EDT  Nanomedicine Company Makes "Nanomachines" that Attack Viruses   Benzinga
Jun 22, 2021
12:49PM EDT  NanoViricides Review: What you Need to Know About the Company   Benzinga
May 17, 2021
06:50AM EDT  Nanoviricides Q3 EPS $(0.19) Up From $(1.24) YoY   Benzinga
Mar 9, 2021
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
09:15AM EST  NanoViricides Says Its COVID-19 Drug Candidates Are Effective In Animal Studies In Support Of FDA Pre-IND Application   Benzinga
Mar 3, 2021
08:58AM EST  Mid-Afternoon Market Update: Crude Oil Down 1.5%; Communication Systems Shares Spike Higher   Benzinga
08:58AM EST  Mid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher   Benzinga
08:57AM EST  Mid-Morning Market Update: Markets Mostly Lower; Target Profit Tops Views   Benzinga
Mar 2, 2021
02:57PM EST  Mid-Afternoon Market Update: Crude Oil Down 1.5%; Communication Systems Shares Spike Higher   Benzinga
12:11PM EST  Mid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher   Benzinga
10:15AM EST  Mid-Morning Market Update: Markets Mostly Lower; Target Profit Tops Views   Benzinga
08:01AM EST  The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data   Benzinga
06:19AM EST  NanoViricides Press Release Highlights 'strong pan-coronavirus effectiveness' Of Its NV-CoV-2 And NV-CoV-2-R Candidates; Says Both Candidates Were 'found to be highly effective in comparison to remdesivir against two distinctly different coronaviruses'   Benzinga
Feb 17, 2021
06:19AM EST  NanoViricides Files Quarterly Report, Says Has $18.39M In Current Assets And Has 'Sufficient Cash'; Also Says Its NV-CoV-2 Candidate Is 'Moving Towards IND'   Benzinga
Feb 8, 2021
07:40AM EST  NanoViricides' Broad-Spectrum Antiviral Drug Candidate Shows Encouraging Action In Preclinical Studies For COVID-19   Benzinga
06:19AM EST  NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies   Benzinga
Jan 27, 2021
06:18AM EST  NanoViricides Issues Press Release COVID-19 Developments   Benzinga
Nov 11, 2020
06:22AM EST  NanoViricides Says Has Engaged Calvert Labs For Safety Pharmacology Studies Of Its Drug For The Treatment Of COVID-19   Benzinga
Oct 15, 2020
06:21AM EDT  NanoViricides Has Filed For Its Annual Report To Strengthen Its Financial Position And Rapidly Developing Novel Coronavirus Drug Program   Benzinga
Sep 16, 2020
06:17AM EDT  NanoViricides Nominates Novel Candidate For Advancing Into Clinical Trials For Treatment of COVID-19   Benzinga
Sep 8, 2020
09:10AM EDT  2020 and July 13, 2020 And Suffered Significant Losses Encouraged To Contact Kehoe Law Firm, P.C.   PR Newswire
Sep 4, 2020
06:53AM EDT  NanoViricides Announces Co. Is Developing Drugs Against SARS-CoV-2 With An Integrated Approach to Combat COVID-19   Benzinga
Sep 3, 2020
08:43AM EDT  REMINDER: NanoViricides To Present COVID-19 Drug Update At LD 500 Virtual Conference At 11:20 AM EDT   Benzinga
08:00AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Sept. 3, 2020: DKNG, AKBA, CORT, NNVC, SWBI   Benzinga
Sep 2, 2020
06:20AM EDT  NanoViricides To Present COVID-19 Drug Update At The LD 500 Virtual Conference Sept. 3   Benzinga
Jul 21, 2020
06:17AM EDT  NanoViricides To Participate In Panel Discussion At The B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020   Benzinga
Jul 20, 2020
06:10PM EDT  Hagens Berman urges investors in NanoViricides, Inc. (NNVC) to submit their losses now. The firm is investigating possible securities fraud, and certain investors may have valuable claims. Hagens Berman also encourages persons who may be able to assist the firms investigation to contact its attorneys.   GlobeNewswire Inc
03:38PM EDT  Altium Capital Management Reports 7.2% Passive Stake In Nanoviricides   Benzinga
Jul 16, 2020
10:52AM EDT  Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of NanoViricides, Inc. (NanoViricides or the Company) (NYSE: NNVC) to determine whether the Company engaged in securities fraud or other unlawful business practices.   GlobeNewswire Inc
Jul 13, 2020
05:08PM EDT  Drugmakers Will Start Coronavirus Vaccine Production By End Of Summer, Trump Health Officials Say   Benzinga
04:59PM EDT  Senior Administration Official Says 'Slate Is Not Closed' For U.S. Government Funding For Covid-19 Vaccines, Expect More Announcements In The Future   Benzinga
06:32AM EDT  NanoVicirides Completes 1.37M Share Common Stock Offering at $8.40/Share   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC